Harrow Health Company Insiders
| HROW Stock | USD 40.94 0.99 2.36% |
Harrow Health employs about 382 people. The company is managed by 19 executives with a total tenure of roughly 892 years, averaging almost 46.0 years of service per executive, having 20.11 employees per reported executive. Recap of Harrow Health's management performance can provide insight into the venture performance.
Harrow Health Management Team Effectiveness
The company has return on total asset (ROA) of 0.0491 % which means that it generated a profit of $0.0491 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0957) %, meaning that it created substantial loss on money invested by shareholders. Harrow Health's management efficiency ratios could be used to measure how well Harrow Health manages its routine affairs as well as how well it operates its assets and liabilities.Harrow Health has a total of 37.04 Million outstanding shares. Over half of Harrow Health's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Harrow Health in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Harrow Health, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Harrow Health Workforce Comparison
Harrow Health is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 14,419. Harrow Health holds roughly 382 in number of employees claiming about 2.65% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21. Harrow Health Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Harrow Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Harrow Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Harrow Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Baum Mark L over three weeks ago Acquisition by Baum Mark L of 15400 shares of Harrow Health at 7.71 subject to Rule 16b-3 | ||
Opaleye Management Inc. over three weeks ago Disposition of 20000 shares by Opaleye Management Inc. of Harrow Health at 53.3457 subject to Rule 16b-3 | ||
Baum Mark L over a month ago Disposition of 180000 shares by Baum Mark L of Harrow Health at 3.95 subject to Rule 16b-3 | ||
Randall Pollard over three months ago Insider Trading | ||
Baum Mark L over six months ago Acquisition by Baum Mark L of 889500 shares of Harrow Health subject to Rule 16b-3 | ||
Opaleye Management Inc. over six months ago Disposition of 1796 shares by Opaleye Management Inc. of Harrow Health at 30.0153 subject to Rule 16b-3 | ||
Opaleye Management Inc. over six months ago Disposition of 3000 shares by Opaleye Management Inc. of Harrow Health at 30.0387 subject to Rule 16b-3 | ||
Baum Mark L over six months ago Disposition of 300363 shares by Baum Mark L of Harrow Health at 23.09 subject to Rule 16b-3 |
Harrow Health Notable Stakeholders
A Harrow Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Harrow Health often face trade-offs trying to please all of them. Harrow Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Harrow Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John MBA | President Division | Profile | |
| CMA CFA | CFO Secretary | Profile | |
| Robert DDS | Special Advisor | Profile | |
| Jamie Webb | Director Relations | Profile | |
| Prashanth Annavajjhala | Chief Staff | Profile | |
| PharmD Shojaei | Chief Officer | Profile | |
| David Moufarrge | VP Technology | Profile | |
| RPh Mannebach | Head Pharmacovigilance | Profile | |
| Brett Burrell | Vice Compliance | Profile | |
| CFA CMA | CFO Sec | Profile | |
| Andrew Livingston | Chief Officer | Profile | |
| Larry MD | Chief Officer | Profile | |
| Mark JD | CEO Chairman | Profile | |
| Patrick Sullivan | Head Commercial | Profile | |
| Kim Barratt | Chief Officer | Profile | |
| Greg DiPasquale | Senior Commercial | Profile | |
| Dennis PharmD | Chief Strategy | Profile | |
| Randall Pollard | Chief Officer | Profile | |
| Michael Biega | Vice Communications | Profile |
About Harrow Health Management Performance
The success or failure of an entity such as Harrow Health often depends on how effective the management is. Harrow Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Harrow management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Harrow management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Harrow Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 182 people.
Please note, the imprecision that can be found in Harrow Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Harrow Health. Check Harrow Health's Beneish M Score to see the likelihood of Harrow Health's management manipulating its earnings.
Harrow Health Workforce Analysis
Traditionally, organizations such as Harrow Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Harrow Health within its industry.Harrow Health Manpower Efficiency
Return on Harrow Health Manpower
| Revenue Per Employee | 522.5K | |
| Revenue Per Executive | 10.5M | |
| Net Loss Per Employee | 45.8K | |
| Net Loss Per Executive | 920.1K | |
| Working Capital Per Employee | 257.4K | |
| Working Capital Per Executive | 5.2M |
Additional Tools for Harrow Stock Analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.